MHRA - Consultation on Early Access to Medicines Scheme (EAMS)

17th August 2021

The UK Early Access to Medicines Scheme (EAMS) is one of the ways through which a patient with a life threatening or seriously debilitating condition can gain access to a medicine before it has gained approval from the UK’s medicines regulatory authority. The MHRA are seeking your views on the proposed legislative changes to clarify the legal basis for EAMS.

Read More

Back to News Archive